By Abigail Townsend
Date: Thursday 16 May 2024
(Sharecast News) - Roche reported positive trial results for its experimental weight loss treatment on Thursday, sending shares in the Swiss drugs group higher.
Currency | US Dollars |
Share Price | $ 878.45 |
Change Today | $ -4.88 |
% Change | -0.55 % |
52 Week High | $884.61 |
52 Week Low | $434.70 |
Volume | 2,023,264 |
Shares Issued | 949.78m |
Market Cap | $834,335m |
RiskGrade | 179 |
Strong Buy | 9 |
Buy | 12 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
16:00 | 303,019 @ $878.45 |
15:59 | 440 @ $878.90 |
15:59 | 340 @ $878.90 |
15:59 | 788 @ $879.00 |
15:59 | 104 @ $879.00 |
You are here: research